| 1 |
33512727 | Tacrolimus (FK506) treatment protects allergen-, IL-5- and IL-13-induced mucosal eosinophilia. | 2021 Jun |
1 |
| 2 |
32067305 | Cytokine profile in children with food allergy following liver transplantation. | 2020 Mar |
1 |
| 3 |
32817992 | Tacrolimus Improves the Implantation Rate in Patients with Elevated Th1/2 Helper Cell Ratio and Repeated Implantation Failure (RIF). | 2020 Aug |
1 |
| 4 |
32932253 | Therapeutic and Immunoregulatory Effects of Tacrolimus in Patients with Refractory Generalized Myasthenia Gravis. | 2020 |
1 |
| 5 |
28060893 | Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis. | 2017 |
1 |
| 6 |
24836681 | Tolerogenic dendritic cells modified by tacrolimus suppress CD4(+) T-cell proliferation and inhibit collagen-induced arthritis in mice. | 2014 Jul |
1 |
| 7 |
16368244 | Inhibition of tumor growth in immunocompromised hosts by restoring type-2 immunity using infusion of G-CSF-treated allogeneic CD8+ leukocytes. | 2005 Dec 21 |
1 |
| 8 |
14767008 | In vitro treatment of dendritic cells with tacrolimus: impaired T-cell activation and IP-10 expression. | 2004 Mar |
1 |
| 9 |
11407316 | Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids). | 2001 Jun |
1 |
| 10 |
10623799 | HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. | 2000 Jan 15 |
1 |
| 11 |
10887335 | Control of IL-5 production by human helper T cells as a treatment for eosinophilic inflammation: comparison of in vitro and in vivo effects between selective and nonselective cytokine synthesis inhibitors. | 2000 Jul |
1 |
| 12 |
10515221 | Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients. | 1999 Oct |
1 |
| 13 |
9469459 | Differential regulation of IL-4 and IL-13 secretion by human basophils: their relationship to histamine release in mixed leukocyte cultures. | 1998 Feb 15 |
1 |
| 14 |
9510155 | Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. | 1998 Mar 15 |
1 |
| 15 |
9667420 | Tacrolimus-induced apoptosis and its prevention by interleukins in mitogen-activated human peripheral-blood mononuclear cells. | 1998 Mar |
2 |
| 16 |
9820545 | Endogenous superallergen protein Fv induces IL-4 secretion from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. | 1998 Nov 15 |
1 |
| 17 |
7518925 | Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells. | 1994 Jul 19 |
1 |
| 18 |
7507316 | Immunosuppressants: tools to investigate the physiological role of cytokines. | 1993 Nov |
2 |
| 19 |
1371491 | Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. | 1992 Jan |
1 |
| 20 |
1380951 | The effects of the antifungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells. | 1992 Jul |
1 |
| 21 |
1383612 | FK-506 inhibits proliferation and IL-4 messenger RNA production by a T-helper 2 cell line. | 1992 Aug |
3 |
| 22 |
1384862 | The effects of FK-506 and cyclosporin A on the proliferation of PHA-stimulated T cells in response to IL-2, IL-4 or IL-6. | 1992 |
1 |
| 23 |
1721312 | FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. | 1991 Dec |
1 |
| 24 |
1702750 | FK506 and pertussis toxin distinguish growth-induced locomotor activation from attractant-stimulated locomotion in human blood lymphocytes. | 1990 Nov |
1 |
| 25 |
2472451 | The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. | 1989 Jul 15 |
1 |